SEC Filing 4: G1 Therapeutics, Inc.

December 5, 2017 9:17am EST

Source: SEC (Index ) via Sqoop

Reporting Person: MedImmune Ventures, Inc.

Transaction Security Shares (Exercise) Price Value Owned After
Sale (S) Common Stock, $0.0001 par value per share 133,906 $19.7500 $2,644,644 3,150,630